Cargando…
Why should pharmacological trials in schizophrenia employ functional magnetic resonance imaging (fMRI)?
Autores principales: | Papanastasiou, Evangelos, Shergill, Sukhwinder S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436305/ https://www.ncbi.nlm.nih.gov/pubmed/33908311 http://dx.doi.org/10.1177/02698811211000773 |
Ejemplares similares
-
Neural correlates of positive and negative symptoms through the illness course: an fMRI study in early psychosis and chronic schizophrenia
por: Vanes, Lucy D., et al.
Publicado: (2019) -
Memory Deficits in Schizophrenia: A Selective Review of Functional Magnetic Resonance Imaging (fMRI) Studies
por: Kraguljac, Nina V., et al.
Publicado: (2013) -
Real-time fMRI neurofeedback to down-regulate superior temporal gyrus activity in patients with schizophrenia and auditory hallucinations: a proof-of-concept study
por: Orlov, Natasza D., et al.
Publicado: (2018) -
Functional magnetic resonance imaging (fMRI) of attention processes in presumed obligate carriers of schizophrenia: preliminary findings
por: Filbey, Francesca Mapua, et al.
Publicado: (2008) -
Why is Clinical fMRI in a Resting State?
por: O'Connor, Erin E., et al.
Publicado: (2019)